{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:42Z","timestamp":1793831262387,"version":"4.6.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-022-10251-9","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T17:02:49Z","timestamp":1654102969000},"page":"137-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combined pre- and post-capillary pulmonary hypertension in left heart disease"],"prefix":"10.1007","volume":"28","author":[{"given":"M.","family":"Riccardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pagnesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sciatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Inciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-6104","authenticated-orcid":false,"given":"E.","family":"Vizzardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"10251_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM (2021) Pulmonary arterial hypertension. N Engl J Med 385:2361\u20132376. https:\/\/doi.org\/10.1056\/NEJMra2000348","journal-title":"N Engl J Med"},{"key":"10251_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JSR, Wachter R et al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942\u2013954. https:\/\/doi.org\/10.1093\/eurheartj\/ehv512","journal-title":"Eur Heart J"},{"key":"10251_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10741-015-9523-6","volume":"21","author":"DD Dixon","year":"2016","unstructured":"Dixon DD, Trivedi A, Shah SJ (2016) Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart Fail Rev 21:285\u2013297. https:\/\/doi.org\/10.1007\/s10741-015-9523-6","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10251_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00059-019-4831-6","volume":"44","author":"S Rosenkranz","year":"2019","unstructured":"Rosenkranz S, Kramer T, Gerhardt F et al (2019) Pulmonary hypertension in HFpEF and HFrEF: pathophysiology, diagnosis, treatment approaches. Herz 44(6):483\u2013490. https:\/\/doi.org\/10.1007\/s00059-019-4831-6","journal-title":"Herz"},{"key":"10251_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/ejhf.630","volume":"18","author":"TM Gorter","year":"2016","unstructured":"Gorter TM, Hoendermis ES, van Veldhuisen DJ et al (2016) Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 18:1472. https:\/\/doi.org\/10.1002\/ejhf.630","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10251_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L et al (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37(1):67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"key":"10251_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","volume":"133","author":"BA Maron","year":"2016","unstructured":"Maron BA, Hess E, Maddox TM et al (2016) Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affair clinical assessment, reporting and tracking program. Circulation 133:1240\u20131248. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020207","journal-title":"Circulation"},{"key":"10251_CR8","doi-asserted-by":"publisher","first-page":"e009729","DOI":"10.1161\/JAHA.118.009729","volume":"7","author":"D Kolte","year":"2018","unstructured":"Kolte D, Lakshmanan S, Jankowich MD, Brittain EL, Maron BA, Choudhary G (2018) Mild pulmonary hypertension is associated with increased mortality: a systematic review and meta-analysis. J Am Heart Assoc 7:e009729. https:\/\/doi.org\/10.1161\/JAHA.118.009729","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10251_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/jim-2020-001291","volume":"68","author":"S Yaghi","year":"2020","unstructured":"Yaghi S, Novikov A, Trandafirescu T (2020) Clinical update on pulmonary hypertension. J Investig Med 68(4):821\u2013827. https:\/\/doi.org\/10.1136\/jim-2020-001291","journal-title":"J Investig Med"},{"key":"10251_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ejhf.860","volume":"20","author":"M Palazzini","year":"2018","unstructured":"Palazzini M, Dardi F, Manes A et al (2018) Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC\/ERS guidelines and insights for future changes. Eur J Heart Fail 20:248\u2013255. https:\/\/doi.org\/10.1002\/ejhf.860","journal-title":"Eur J Heart Fail"},{"key":"10251_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2018","author":"JL Vachi\u00e9ry","year":"2019","unstructured":"Vachi\u00e9ry JL, Tedford RJ, Rosenkranz S et al (2019) Pulmonary hypertension due to left heart disease. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01897-2018","journal-title":"Eur Respir J"},{"issue":"22","key":"10251_CR12","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","volume":"76","author":"AM Bradley","year":"2020","unstructured":"Bradley AM, Gabor K, Anjali V et al (2020) Cardiopulmonary hemodynamics in pulmonary hypertension and heart failure: JACC review topic of the week. J Am Coll Cardiol 76(22):2671\u20132681. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.007","journal-title":"J Am Coll Cardiol"},{"key":"10251_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1536\/ihj.19-476","volume":"61","author":"K Sugimoto","year":"2020","unstructured":"Sugimoto K, Yoshihisa A et al (2020) Significance of pulmonary vascular resistance and diastolic pressure gradient on the new definition of combined post-capillary pulmonary hypertension. Int Heart J 61:301\u2013307. https:\/\/doi.org\/10.1536\/ihj.19-476","journal-title":"Int Heart J"},{"key":"10251_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","volume":"76","author":"BA Maron","year":"2020","unstructured":"Maron BA, Kovacs G, Vaidya A et al (2020) Cardiopulmonary hemodynamics in pulmonary hypertension and heart failure. J Am Coll Cardiol 76:2671\u20132681. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.007","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10251_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","volume":"102","author":"DL Moraes","year":"2000","unstructured":"Moraes DL, Colucci WS, Givertz MM (2000) Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 102(14):1718\u20131723. https:\/\/doi.org\/10.1161\/01.CIR.102.14.1718","journal-title":"Circulation"},{"issue":"2","key":"10251_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1042\/CS20130296]","volume":"127","author":"S Azarbar","year":"2014","unstructured":"Azarbar S, Dupuis J (2014) Lung capillary injury and repair in left heart disease: a new target for therapy? Clin Sci 127(2):65\u201376. https:\/\/doi.org\/10.1042\/CS20130296]","journal-title":"Clin Sci"},{"issue":"117","key":"10251_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1183\/09059180.00002210","volume":"19","author":"N Saouti","year":"2010","unstructured":"Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A (2010) The arterial load in pulmonary hypertension. Eur Respir Rev 19(117):197\u2013203. https:\/\/doi.org\/10.1183\/09059180.00002210","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10251_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.111.186072","volume":"59","author":"Y Chen","year":"2012","unstructured":"Chen Y, Guo H, Xu D et al (2012) Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59(6):1170\u20131178. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.186072","journal-title":"Hypertension"},{"issue":"4","key":"10251_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jacc2016.05.045","volume":"68","author":"OB Yehuda","year":"2016","unstructured":"Yehuda OB, Rubin LJ (2016) Pulmonary hypertension overlap syndrome, a real entity? JACC 68(4):379\u201381380. https:\/\/doi.org\/10.1016\/j.jacc2016.05.045","journal-title":"JACC"},{"issue":"23","key":"10251_CR20","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2016.09.942","volume":"68","author":"TR Assad","year":"2016","unstructured":"Assad TR, Hemnes AR, Larkin EK et al (2016) Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension. J Am Coll Cardiol 68(23):2525\u20132536. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.942","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10251_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.healun.2011.02.016","volume":"30","author":"ME Pugh","year":"2011","unstructured":"Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR (2011) Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Hear Lung Transplant 30(8):904\u2013911. https:\/\/doi.org\/10.1016\/j.healun.2011.02.016","journal-title":"J Hear Lung Transplant"},{"issue":"4","key":"10251_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1183\/09031936.00030312","volume":"41","author":"J West","year":"2013","unstructured":"West J, Niswender KD, Johnson JA et al (2013) A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J 41(4):861\u2013871. https:\/\/doi.org\/10.1183\/09031936.00030312","journal-title":"Eur Respir J"},{"issue":"2","key":"10251_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1152\/jappl.1989.66.2.1008","volume":"66","author":"L Hyman","year":"1989","unstructured":"Hyman L, Howard L, Hauth TA et al (1989) Endothelin produces pulmonary vasoconstriction and systemic vasodilatation. J Appl Physiol 66(2):1008\u20131012. https:\/\/doi.org\/10.1152\/jappl.1989.66.2.1008","journal-title":"J Appl Physiol"},{"issue":"2","key":"10251_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3181\/00379727-199-43342","volume":"199","author":"P Hassoun","year":"1992","unstructured":"Hassoun P, Thappa V, Landman M et al (1992) endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med 199(2):165\u2013170. https:\/\/doi.org\/10.3181\/00379727-199-43342","journal-title":"Proc Soc Exp Biol Med"},{"key":"10251_CR25","doi-asserted-by":"publisher","DOI":"10.1113\/JP275987","author":"RWB Van Duin","year":"2019","unstructured":"Van Duin RWB, Stam K, Cai Z et al (2019) Transition from post capillary pulmonary hypertension to combined pre- and post-capillary pulmonary hypertension in swine: a key role for endothelin. J Physiol. https:\/\/doi.org\/10.1113\/JP275987","journal-title":"J Physiol"},{"issue":"1","key":"10251_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045893217745019","volume":"8","author":"DF Meoli","year":"2018","unstructured":"Meoli DF, Ru SuY, Brittain EV, Robbins IV et al (2018) the transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Pulm Circ 8(1):1\u20138. https:\/\/doi.org\/10.1177\/2045893217745019","journal-title":"Pulm Circ"},{"key":"10251_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/cvr\/cvu215","volume":"104","author":"J Yang","year":"2014","unstructured":"Yang J, Li X, Morrel NW (2014) ID protein in the vasculature: from molecular biology to cardiopulmonary medicine. Cardiovasc Res 104:388\u2013398. https:\/\/doi.org\/10.1093\/cvr\/cvu215","journal-title":"Cardiovasc Res"},{"key":"10251_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/ATVBAHA.107.141200","volume":"27","author":"RE Morty","year":"2007","unstructured":"Morty RE et al (2007) Dysregulated bone morphogenetic protein signalling in monocrotaline-induced pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 27:1072\u20131078. https:\/\/doi.org\/10.1161\/ATVBAHA.107.141200","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10251_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1152\/ajplung.00054.2013","volume":"305","author":"Y Yang","year":"2013","unstructured":"Yang Y et al (2013) ID proteins are critical downstream effectors of BMP signalling in human pulmonary arterial smooth muscle cell. Am J Physiol Lung Cell Mol Physiol 305:312\u2013321. https:\/\/doi.org\/10.1152\/ajplung.00054.2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10251_CR30","doi-asserted-by":"publisher","first-page":"19572","DOI":"10.1038\/s41598-019-55700-y","volume":"9","author":"MJ Arwood","year":"2019","unstructured":"Arwood MJ, Vahabi N, Lteif C et al (2019) Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension. Sci Rep 9(1):19572. https:\/\/doi.org\/10.1038\/s41598-019-55700-y","journal-title":"Sci Rep"},{"issue":"4","key":"10251_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","volume":"1","author":"WL Miller","year":"2013","unstructured":"Miller WL, Grill DE, Borlaug BA (2013) Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Hear Fail 1(4):290\u2013299. https:\/\/doi.org\/10.1016\/j.jchf.2013.05.001","journal-title":"JACC Hear Fail"},{"issue":"23","key":"10251_CR32","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.jacc.2016.10.013","volume":"68","author":"JA Leopold","year":"2016","unstructured":"Leopold JA (2016) Biological phenotyping of combined post-capillary and pre-capillary pulmonary hypertension: focus on pulmonary vascular remodeling. J Am Coll Cardiol 68(23):2537\u20132539. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.013","journal-title":"J Am Coll Cardiol"},{"key":"10251_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","volume":"68","author":"CF Opitz","year":"2016","unstructured":"Opitz CF, Hoeper MM, Gibbs JSR et al (2016) Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum. J Am Coll Cardiol 68:368\u2013378. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.047","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10251_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ahj.2012.01.024","volume":"163","author":"JJ Ryan","year":"2012","unstructured":"Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S (2012) Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J 163(4):589\u2013594. https:\/\/doi.org\/10.1016\/j.ahj.2012.01.024","journal-title":"Am Heart J"},{"issue":"1","key":"10251_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","volume":"7","author":"IM Robbins","year":"2014","unstructured":"Robbins IM, Hemnes AR, Pugh ME et al (2014) High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Hear Fail 7(1):116\u2013122. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000468","journal-title":"Circ Hear Fail"},{"issue":"1","key":"10251_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.112.111302","volume":"127","author":"N Fujimoto","year":"2013","unstructured":"Fujimoto N, Borlaug BA, Lewis GD et al (2013) Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 127(1):55\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.111302","journal-title":"Circulation"},{"key":"10251_CR37","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1378\/chest.13-1510","volume":"5","author":"P Pellegrini","year":"2014","unstructured":"Pellegrini P, Rossi A et al (2014) Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest J 5:1064\u20131070. https:\/\/doi.org\/10.1378\/chest.13-1510","journal-title":"Chest J"},{"issue":"4","key":"10251_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5339\/gcsp.2015.58","volume":"2015","author":"S Ghio","year":"2015","unstructured":"Ghio S, Schirinzi S, Pica S (2015) Pulmonary arterial compliance: how and why should we measure it? Glob Cardiol Sci Pract 2015(4):58. https:\/\/doi.org\/10.5339\/gcsp.2015.58","journal-title":"Glob Cardiol Sci Pract"},{"issue":"11","key":"10251_CR39","doi-asserted-by":"publisher","first-page":"e0188383","DOI":"10.1371\/journal.pone.0188383","volume":"12","author":"S Ghio","year":"2017","unstructured":"Ghio S, Crimi G, Pica S et al (2017) Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension. PLoS ONE 12(11):e0188383. https:\/\/doi.org\/10.1371\/journal.pone.0188383","journal-title":"PLoS ONE"},{"issue":"5","key":"10251_CR40","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1378\/chest.10-1269","volume":"139","author":"JD Rich","year":"2011","unstructured":"Rich JD, Shah SJ, Swamy RS, Kamp A, Rich S (2011) Inaccuracy of Doppler echocardiography estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest 139(5):988\u2013993. https:\/\/doi.org\/10.1378\/chest.10-1269","journal-title":"Chest"},{"issue":"3","key":"10251_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cardfail.2011.12.003","volume":"18","author":"T Damy","year":"2012","unstructured":"Damy T et al (2012) Prevalence of association with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail 18(3):216\u2013225. https:\/\/doi.org\/10.1016\/j.cardfail.2011.12.003","journal-title":"J Card Fail"},{"key":"10251_CR42","doi-asserted-by":"publisher","first-page":"e000408","DOI":"10.1136\/openhrt-2016-000408","volume":"3","author":"S Ghio","year":"2016","unstructured":"Ghio S, Pica S, Klersy C et al (2016) Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy. Open Heart 3:e000408. https:\/\/doi.org\/10.1136\/openhrt-2016-000408","journal-title":"Open Heart"},{"key":"10251_CR43","doi-asserted-by":"publisher","first-page":"H1373","DOI":"10.1152\/ajpheart.00157.2013","volume":"305","author":"M Guazzi","year":"2013","unstructured":"Guazzi M, Bandera F, Pelissero G et al (2013) Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 305:H1373\u2013H1381. https:\/\/doi.org\/10.1152\/ajpheart.00157.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10251_CR44","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/ehjci\/jex133","volume":"19","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ et al (2018) Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs post-capillary pulmonary hypertension. Eur Heart J Cardiovasc Imaging 19:425\u2013432. https:\/\/doi.org\/10.1093\/ehjci\/jex133","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10251_CR45","first-page":"272","volume":"10","author":"M Todaro","year":"2020","unstructured":"Todaro M, Carery S et al (2020) Echocardiographic evaluation of right ventricular-arterial coupling in pulmonary hypertension. Am J Cardiovasc Dis 10(4):272\u2013283. PMID: 33224574; PMCID: PMC7675169","journal-title":"Am J Cardiovasc Dis"},{"issue":"10","key":"10251_CR46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","volume":"192","author":"M Gerges","year":"2015","unstructured":"Gerges M, Gerges C, Pistritto AM et al (2015) Pulmonary hypertension in heart failure epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 192(10):1234\u20131246. https:\/\/doi.org\/10.1164\/rccm.201503-0529OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10251_CR47","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/ejhf.1862","volume":"22","author":"E Santiago-Vacas","year":"2020","unstructured":"Santiago-Vacas E, Lup\u00f3n J, Gavidia-Bovadilla G, Gual-Capllonch F, de Antonio M, Domingo M, N\u00fa\u00f1ez J, Zamora E, Teis A, Moliner P, Codina P, Santesmases J, Bayes-Genis A (2020) Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15-year prospective longitudinal trajectories in survivors. Eur J Heart Fail 22(7):1214\u20131225. https:\/\/doi.org\/10.1002\/ejhf.1862. Epub 2020 May 25 PMID: 32452102","journal-title":"Eur J Heart Fail"},{"key":"10251_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1164\/rccm.201004-0601OC","volume":"183","author":"JS Arkles","year":"2011","unstructured":"Arkles JS, Opotowsky AR, Ojeda J et al (2011) Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 183:268\u2013276. https:\/\/doi.org\/10.1164\/rccm.201004-0601OC","journal-title":"Am J Respir Crit Care Med"},{"key":"10251_CR49","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1002\/ehf2.13496","volume":"8","author":"C Janei","year":"2021","unstructured":"Janei C, Kadar R et al (2021) Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension. ESC Heart Failure 8:3975\u20133983. https:\/\/doi.org\/10.1002\/ehf2.13496","journal-title":"ESC Heart Failure"},{"key":"10251_CR50","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1055\/a-1555-0345","volume":"146","author":"M Held","year":"2021","unstructured":"Held M, Weiner S, Walthelm J et al (2021) Funktionelle charakterisierung von patienten mit isoliert postkapill\u00e4rer oder kombiniert post- und pr\u00e4kapill\u00e4rer pulmonaler hypertonie. Dtsch Med Wochenschr 146:e88\u2013e94. https:\/\/doi.org\/10.1055\/a-1555-0345","journal-title":"Dtsch Med Wochenschr"},{"key":"10251_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijcard.2016.03.035","volume":"212","author":"M Scalia","year":"2016","unstructured":"Scalia M, Scalia IG, Kierle R et al (2016) ePLAR\u2014the echocardiographic pulmonary to left atrial ratio\u2014a novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension. Int J Cardiol 212:379\u2013386. https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.035","journal-title":"Int J Cardiol"},{"issue":"1","key":"10251_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10741-015-9520-9","volume":"21","author":"M Cameli","year":"2016","unstructured":"Cameli M, Mandoli GE, Loiacono F et al (2016) Left atrial strain: a new parameter for assessment of left ventricular filling pressure. Heart Fail Rev 21(1):65\u201376. https:\/\/doi.org\/10.1007\/s10741-015-9520-9","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10251_CR53","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/echo.13094","volume":"33","author":"M Cameli","year":"2016","unstructured":"Cameli M, Sparla S, Losito M et al (2016) Correlation of left atrial strain and Doppler measurements with invasive measurement of left ventricular end-diastolic pressure in patients stratified for different values of ejection fraction. Echocardiography (Mount Kisco, NY) 33(3):398\u2013405. https:\/\/doi.org\/10.1111\/echo.13094","journal-title":"Echocardiography (Mount Kisco, NY)"},{"key":"10251_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7120-8-14","author":"M Cameli","year":"2010","unstructured":"Cameli M, Lisi M, Mondillo S et al (2010) Left atrial longitudinal strain by speckle tracking echocardiography correlates well with left ventricular filling pressures in patients with heart failure, Cardiovasc. Ultrasound. https:\/\/doi.org\/10.1186\/1476-7120-8-14. PMID: 20409332; PMCID: PMC2868789","journal-title":"Ultrasound"},{"key":"10251_CR55","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001171","author":"J Zanaboni","year":"2021","unstructured":"Zanaboni J, Panizza A, Marino P (2021) Left atrial conduit function modulates right ventricular afterload, exercise capacity and survival in heart failure patients. J Cardiovasc Med. https:\/\/doi.org\/10.2459\/JCM.0000000000001171","journal-title":"J Cardiovasc Med"},{"issue":"292","key":"10251_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijcard.2019.05.025","volume":"1","author":"A Venkateshvaran","year":"2019","unstructured":"Venkateshvaran A, Manouras A, Kjellstr\u00f6m B et al (2019) The additive value of echocardiographic pulmonary to left atrial global strain ratio in the diagnosis of pulmonary hypertension. Int J Cardiol 1(292):205\u2013210. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.025","journal-title":"Int J Cardiol"},{"issue":"3","key":"10251_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jcmg.2008.08.007","volume":"2","author":"J Sanz","year":"2009","unstructured":"Sanz J, Kariisa M, Dellegrottaglie S et al (2009) Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2(3):286\u2013295. https:\/\/doi.org\/10.1016\/j.jcmg.2008.08.007","journal-title":"JACC Cardiovasc Imaging"},{"key":"10251_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diii.2019.12.008","volume":"101","author":"P Habert","year":"2020","unstructured":"Habert P, Capron T, Hubert S et al (2020) Quantification of right ventricular extracellular volume in pulmonary hypertension using cardiac magnetic resonance imaging. Diagn Interv Imaging 101:311\u2013320. https:\/\/doi.org\/10.1016\/j.diii.2019.12.008","journal-title":"Diagn Interv Imaging"},{"key":"10251_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1148\/radiol.2018180120","volume":"289","author":"CS Johns","year":"2018","unstructured":"Johns CS, Wild JM et al (2018) Identifying at-risk patients with combined pre- and post-capillary pulmonary hypertension using interventricular septal angle at cardiac MRI. Radiology 289:61\u201368. https:\/\/doi.org\/10.1148\/radiol.2018180120","journal-title":"Radiology"},{"issue":"6","key":"10251_CR60","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/CIRCIMAGING.112.976654","volume":"5","author":"AR Opotowsky","year":"2012","unstructured":"Opotowsky AR, Ojeda J, Rogers F et al (2012) A simple echocardiographic prediction rule for hemodynamics in pulmonary hypertension. Circ Cardiovasc Imaging 5(6):765\u2013775. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.976654","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10251_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.echo.2014.09.004","volume":"28","author":"M D\u2019Alto","year":"2015","unstructured":"D\u2019Alto M, Romeo E, Argiento P et al (2015) Echocardiographic prediction of pre- versus postcapillary pulmonary hypertension. J Am Soc Echocardiogr 28(1):108\u2013115. https:\/\/doi.org\/10.1016\/j.echo.2014.09.004","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10251_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pcad.2016.05.003","volume":"59","author":"R Naeije","year":"2016","unstructured":"Naeije R, D\u2019Alto M (2016) The diagnostic challenge of group 2 pulmonary hypertension. Prog Cardiovasc Dis 59(1):22\u201329. https:\/\/doi.org\/10.1016\/j.pcad.2016.05.003","journal-title":"Prog Cardiovasc Dis"},{"issue":"00","key":"10251_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehab368","volume":"2021","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021(00):1\u2013128. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"1","key":"10251_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2006.01.067","volume":"115","author":"S Braun","year":"2007","unstructured":"Braun S, Schr\u00f6tter H, Schmeisser A, Strasser RH (2007) Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Int J Cardiol 115(1):67\u201372. https:\/\/doi.org\/10.1016\/j.ijcard.2006.01.067","journal-title":"Int J Cardiol"},{"issue":"9","key":"10251_CR65","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.healun.2006.04.011","volume":"25","author":"W Von Scheidt","year":"2006","unstructured":"Von Scheidt W, Costard-Jaeckle A, Stempfle HU et al (2006) Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. J Hear Lung Transplant 25(9):1070\u20131076. https:\/\/doi.org\/10.1016\/j.healun.2006.04.011","journal-title":"J Hear Lung Transplant"},{"issue":"2","key":"10251_CR66","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0002-9149(82)90183-7","volume":"50","author":"Y Yui","year":"1982","unstructured":"Yui Y, Nakajima H, Kawai C, Murakami T (1982) Prostacyclin therapy in patients with congestive heart failure. Am J Cardiol 50(2):320\u2013324. https:\/\/doi.org\/10.1016\/0002-9149(82)90183-7","journal-title":"Am J Cardiol"},{"issue":"1","key":"10251_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","volume":"134","author":"RM Califf","year":"1997","unstructured":"Califf RM, Adams KF, McKenna WJ et al (1997) A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 134(1):44\u201354. https:\/\/doi.org\/10.1016\/S0002-8703(97)70105-4","journal-title":"Am Heart J"},{"issue":"21","key":"10251_CR68","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","volume":"98","author":"G S\u00fctsch","year":"1998","unstructured":"S\u00fctsch G, Kiowski W, Yan XW et al (1998) Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98(21):2262\u20132268. https:\/\/doi.org\/10.1161\/01.CIR.98.21.2262","journal-title":"Circulation"},{"key":"10251_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","volume":"5","author":"M Packer","year":"2017","unstructured":"Packer M, McMurray JJV, Krum H et al (2017) Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronich heart failure: primary results of the ENABLE trials. JACC Heart Fail 5:317\u2013326. https:\/\/doi.org\/10.1016\/j.jchf.2017.02.021","journal-title":"JACC Heart Fail"},{"key":"10251_CR70","doi-asserted-by":"publisher","unstructured":"Vachl\u00e9ry JL, Delcroix, Al-Hiti H et al (2018) Macitentan in pulmonary hypertension due to left ventricular dysfunction. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01886-2017","DOI":"10.1183\/13993003.01886-2017"},{"key":"10251_CR71","unstructured":"ClinicalTrials.gov Identifier: NCT03153111. (2017)"},{"key":"10251_CR72","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","volume":"50","author":"M Guazzi","year":"2007","unstructured":"Guazzi M, Samaja M, Arena R et al (2007) Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 50:2136\u20132144. https:\/\/doi.org\/10.1016\/j.jacc.2007.07.078","journal-title":"J Am Coll Cardiol"},{"key":"10251_CR73","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","volume":"124","author":"M Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R (2011) Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124:164\u2013174. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.983866","journal-title":"Circulation"},{"issue":"12","key":"10251_CR74","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.jacc.2004.09.041","volume":"44","author":"M Guazzi","year":"2004","unstructured":"Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD (2004) The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44(12):2339\u20132348. https:\/\/doi.org\/10.1016\/j.jacc.2004.09.041","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10251_CR75","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jama.2013.2024","volume":"309","author":"MM Redfield","year":"2013","unstructured":"Redfield MM, Chen HH, Borlaug BA et al (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction. JAMA 309(12):1268. https:\/\/doi.org\/10.1001\/jama.2013.2024","journal-title":"JAMA"},{"issue":"36","key":"10251_CR76","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","volume":"36","author":"ES Hoendermis","year":"2015","unstructured":"Hoendermis ES, Liu LC, Hummel YM, Van der Meer P, De Boer RA, Berger RMF et al (2015) ELects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur Heart J 36(36):2565\u20132573. https:\/\/doi.org\/10.1093\/eurheartj\/ehv336","journal-title":"Eur Heart J"},{"key":"10251_CR77","doi-asserted-by":"crossref","unstructured":"Cooper TJ, Cleland JGF, Guazzi M et al (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (SilHF) study. Eur J Heart Fail","DOI":"10.1002\/ejhf.2527"},{"key":"10251_CR78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijcard.2018.12.078","volume":"283","author":"T Kramer","year":"2019","unstructured":"Kramer T, Dumitrescu D, Gerhardt F et al (2019) Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension. Int J Cardiol 283:152\u2013158. https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.078","journal-title":"Int J Cardiol"},{"key":"10251_CR79","doi-asserted-by":"publisher","unstructured":"Behr J, Nathan SD, Wuyts WA, Mogulkoc Bishop N, Bouros DE, Antoniou K, Guiot J, Kramer MR, Kirchgaessler KU, Bengus M, Gilberg F, Perjesi A, Harari S, Wells AU (2021) Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med 9(1):85\u201395. https:\/\/doi.org\/10.1016\/S2213-2600(20)30356-8. Epub 2020 Aug 18. Erratum in: Lancet Respir Med. 2021 Apr;9(4):e38. PMID: 32822614","DOI":"10.1016\/S2213-2600(20)30356-8"},{"issue":"1","key":"10251_CR80","doi-asserted-by":"publisher","first-page":"CD012621","DOI":"10.1002\/14651858.CD012621.pub2","volume":"1","author":"H Barnes","year":"2019","unstructured":"Barnes H, Brown Z, Burns A, Williams T (2019) Phosphodiesterase 5 inhibitors for pulmonary hypertension. Cochrane Database Syst Rev 1(1):CD012621. https:\/\/doi.org\/10.1002\/14651858.CD012621.pub2. PMID: 30701543; PMCID: PMC6354064","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10251_CR81","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/phar.2314","volume":"39","author":"K Kido","year":"2019","unstructured":"Kido K, Coons JC (2019) Efficacy and safety of the use of pulmonary arterial hypertension pharmacotherapy in patients with pulmonary hypertension secondary to left heart disease: a systematic review. Pharmacotherapy 39(9):929\u2013945. https:\/\/doi.org\/10.1002\/phar.2314. PMID: 31349390","journal-title":"Pharmacotherapy"},{"key":"10251_CR82","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","volume":"128","author":"D Bonderman","year":"2013","unstructured":"Bonderman D, Ghio S, Felix SB et al (2013) Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation 128:502\u2013511. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001458","journal-title":"Circulation"},{"key":"10251_CR83","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.14-0106","volume":"146","author":"D Bonderman","year":"2014","unstructured":"Bonderman D, Pretsch I, Steringer-Mascherbauer R et al (2014) Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. Chest 146:1274\u20131285. https:\/\/doi.org\/10.1378\/chest.14-0106","journal-title":"Chest"},{"key":"10251_CR84","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382:1883\u20131893. https:\/\/doi.org\/10.1056\/NEJMoa1915928","journal-title":"N Engl J Med"},{"key":"10251_CR85","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12471-016-0902-y","volume":"24","author":"DO Verschure","year":"2016","unstructured":"Verschure DO et al (2016) Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation. Neth Heart J 24:701\u2013708. https:\/\/doi.org\/10.1007\/s12471-016-0902-y","journal-title":"Neth Heart J"},{"issue":"3","key":"10251_CR86","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jcin.2018.09.021","volume":"12","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang J, Chen M et al (2019) Pulmonary artery denervation significantly increases 6-min walk distance for patients with combined pre- and post-capillary pulmonary hypertension associated with left heart failure: the PADN-5 study. JACC Cardiovasc Interv 12(3):274\u2013284. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.021","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10251_CR87","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jacc.2020.06.067","volume":"76","author":"MM Hoeper","year":"2020","unstructured":"Hoeper MM (2020) Pulmonary artery denervation, the new kid on the block? JACC 76(8):927\u2013929. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.067","journal-title":"JACC"},{"issue":"4","key":"10251_CR88","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.tcm.2020.04.005","volume":"31","author":"A Constantine","year":"2021","unstructured":"Constantine A, Dimopoulos K (2021) Pulmonary artery denervation for pulmonary arterial hypertension. Trends Cardiovasc Med 31(4):252\u2013260. https:\/\/doi.org\/10.1016\/j.tcm.2020.04.005","journal-title":"Trends Cardiovasc Med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-022-10251-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T06:19:29Z","timestamp":1675664369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-022-10251-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["10251"],"URL":"https:\/\/doi.org\/10.1007\/s10741-022-10251-9","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"10 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}